loading
전일 마감가:
$1.39
열려 있는:
$1.41
하루 거래량:
331.39K
Relative Volume:
0.44
시가총액:
$44.84M
수익:
-
순이익/손실:
$-69.00M
주가수익비율:
-0.5144
EPS:
-2.78
순현금흐름:
$-55.26M
1주 성능:
+5.93%
1개월 성능:
+7.52%
6개월 성능:
-73.76%
1년 성능:
-82.92%
1일 변동 폭
Value
$1.34
$1.47
1주일 범위
Value
$1.34
$1.495
52주 변동 폭
Value
$1.05
$10.16

Acrivon Therapeutics Inc Stock (ACRV) Company Profile

Name
명칭
Acrivon Therapeutics Inc
Name
전화
617-207-8979
Name
주소
480 ARSENAL WAY, SUITE 100, WATERTOWN
Name
직원
78
Name
트위터
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
ACRV's Discussions on Twitter

ACRV을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ACRV
Acrivon Therapeutics Inc
1.43 43.58M 0 -69.00M -55.26M -2.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-05 재개 Piper Sandler Overweight
2025-01-31 개시 KeyBanc Capital Markets Overweight
2024-09-16 업그레이드 Ladenburg Thalmann Neutral → Buy
2024-04-29 다운그레이드 Ladenburg Thalmann Buy → Neutral
2024-03-01 개시 JMP Securities Mkt Outperform
2023-12-15 재개 Jefferies Buy
2023-10-05 개시 Maxim Group Buy
2023-06-02 개시 Oppenheimer Outperform
2023-05-08 개시 BMO Capital Markets Outperform
2023-04-27 개시 Ladenburg Thalmann Buy
2023-04-20 개시 H.C. Wainwright Buy
2022-12-12 개시 Cowen Outperform
2022-12-12 개시 Jefferies Buy
2022-12-12 개시 Piper Sandler Overweight
모두보기

Acrivon Therapeutics Inc 주식(ACRV)의 최신 뉴스

pulisher
05:29 AM

Is Acrivon Therapeutics Inc. stock a good hedge against inflationPotential Rocket List - Newser

05:29 AM
pulisher
05:10 AM

What is the dividend policy of Acrivon Therapeutics Inc. stockGet timely market insights for better trades - jammulinksnews.com

05:10 AM
pulisher
Jul 24, 2025

How high can Acrivon Therapeutics Inc. stock price go in 2025Free Group Entry - Newser

Jul 24, 2025
pulisher
Jul 23, 2025

Acrivon Therapeutics Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Acrivon Therapeutics Inc. stockRapid wealth creation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Acrivon Therapeutics Inc. a good long term investmentHigh-octane investment gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Here's Why We're Watching Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Acrivon Therapeutics Inc. stock priceHigh-profit capital plays - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 17, 2025

Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionFree Insider Trading Tips - beatles.ru

Jul 17, 2025
pulisher
Jul 17, 2025

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 17, 2025
pulisher
Jul 17, 2025

Analysts Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Target Price at $17.71 - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

What makes Acrivon Therapeutics Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Cantor Fitzgerald sets Acrivon stock to Overweight on AP3 platform - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

How Acrivon Therapeutics Inc. stock performs during market volatilityAlpha Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - GlobeNewswire Inc.

Jul 15, 2025
pulisher
Jul 12, 2025

(ACRV) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 11, 2025

Acrivon Therapeutics (NASDAQ:ACRV) Trading 0.7% Higher – Still a Buy? - Defense World

Jul 11, 2025
pulisher
Jun 22, 2025

Acrivon Therapeutics, Inc.(NasdaqGM: ACRV) dropped from S&P Global BMI Index - MarketScreener

Jun 22, 2025
pulisher
Jun 21, 2025

Learn to Evaluate (ACRV) using the Charts - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 13, 2025

Acrivon Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

Analysts Offer Predictions for ACRV FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Long Term Trading Analysis for (ACRV) - news.stocktradersdaily.com

Jun 10, 2025

Acrivon Therapeutics Inc (ACRV) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Acrivon Therapeutics Inc 주식 (ACRV) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
PERCEPTIVE ADVISORS LLC
10% Owner
May 01 '25
Sale
1.34
298,886
400,507
3,104,139
PERCEPTIVE ADVISORS LLC
10% Owner
Apr 25 '25
Sale
1.95
1,054,669
2,056,605
4,306,189
PERCEPTIVE ADVISORS LLC
10% Owner
Apr 29 '25
Sale
1.41
250,000
352,500
3,840,906
PERCEPTIVE ADVISORS LLC
10% Owner
Apr 28 '25
Sale
1.56
215,283
335,841
4,090,906
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):